Singapore biotech firm JN Medsys develops a PCR test kit that specifically detects for the Omicron variant with high accuracy

SINGAPORE, Jan. 12, 2022 /PRNewswire/ -- Singapore-based biotech firm, JN Medsys announces that it has developed a new PCR kit that detects for SARS-CoV-2 and identifies if the Omicron variant

Related Keywords

South Africa ,Singapore ,Kostenloser Wertpapierhandel ,Gwen Xie ,Singapore Health Sciences Authority ,World Health Organization ,Protect Omivar ,Health Sciences Authority ,Biotech ,Firm ,Edsys ,Evelops ,Pest ,Specifically ,Detects ,Micron ,Variant ,Thigh ,Accuracy ,